Literature DB >> 7589025

Randomised crossover comparison of adrenal suppressive effects of dermal creams containing glucocorticosteroids.

H W Visscher1, J T Ebels, G A Roders, J G Jonkman.   

Abstract

To compare the effect of multiple dose treatment with fatty cream 0.1% hydrocortisone-17-butyrate (LLFC) and fatty cream 0.1% mometasone furoate (EFC), under occlusion on adrenal function, we performed an open label, randomised, two-period crossover study, lasting 30 days, in 12 healthy, male volunteers (age 18-45 y). Morning plasma cortisol and ACTH concentrations were determined before, during, and after the treatments, and a Synacthen test was performed before and during the treatments. Both agents suppressed plasma cortisol concentrations, EFC significantly more than LLFC. ACTH concentrations were normal and were comparable between the two treatments throughout the studies, while the Synacthen tests showed normal rises in cortisol levels. Both treatments were well tolerated. We conclude that EFC has a stronger suppressive effect on plasma cortisol values than LLFC, although for short duration treatments both suppressive effects are transient.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589025     DOI: 10.1007/BF00192736

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  2 in total

1.  Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.

Authors:  A Kecskés; D Heger-Mahn; R K Kuhlmann; L Lange
Journal:  J Am Acad Dermatol       Date:  1993-10       Impact factor: 11.527

2.  Safety and efficacy of mometasone furoate cream in the treatment of steroid responsive dermatoses.

Authors:  J W Kelly; G D Cains; M Rallings; S J Gilmore
Journal:  Australas J Dermatol       Date:  1991       Impact factor: 2.875

  2 in total
  2 in total

Review 1.  Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.

Authors:  A Prakash; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 11.431

Review 2.  Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.

Authors:  Fabrizio Spada; Tanya M Barnes; Kerryn A Greive
Journal:  Australas J Dermatol       Date:  2018-02-07       Impact factor: 2.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.